| Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development M Stanchina, D Soong, B Zheng-Lin, JM Watts, J Taylor Cancers 12 (11), 3225, 2020 | 65 | 2020 |
| Effects of a month‐long napping regimen in older individuals SS Campbell, MD Stanchina, JR Schlang, PJ Murphy Journal of the American Geriatrics Society 59 (2), 224-232, 2011 | 60 | 2011 |
| The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions SG Iyer, L Elias, M Stanchina, J Watts Frontiers in Oncology 12, 2022 | 18 | 2022 |
| CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A M Stanchina, A Pastore, S Devlin, C Famulare, E Stein, J Taylor Journal of Hematology & Oncology 12 (1), 1-4, 2019 | 10 | 2019 |
| Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1. 1.529 (“Omicron”) SARS-CoV-2 Variant Wave SA Kareff, A Khan, P Barreto-Coelho, SG Iyer, B Pico, M Stanchina, ... Cancers 14 (19), 4629, 2022 | 6 | 2022 |
| Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date SG Iyer, M Stanchina, TJ Bradley, J Watts Cancer management and research, 2267-2272, 2022 | 6 | 2022 |
| BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon M Stanchina, Z McKinnell, JH Park, EM Stein, SF Cai, J Taylor Leukemia Research Reports 14, 100211, 2020 | 6 | 2020 |
| Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS) M Stanchina, S Chaudhry, M Karr, J Taylor Hemato 2 (2), 217-236, 2021 | 5 | 2021 |
| Advances in acute myeloid leukemia: recently approved therapies and drugs in development. Cancers 12, E3225 M Stanchina, D Soong, B Zheng-Lin, JM Watts, J Taylor | 5 | 2020 |
| Abstract B123: Prevalence of COVID-19 among hematology/oncology patients and providers of a community-facing county health system during the B1. 1.529 (“Omicron”) SARS-CoV-2 … A Khan, SA Kareff, P Barreto-Coelho, S Iyer, B Pico, M Stanchina, ... Cancer Epidemiology, Biomarkers & Prevention 32 (1_Supplement), B123-B123, 2023 | 3 | 2023 |
| Octogenarians with AML Can Have Durable Remissions with Venetoclax and Hypomethylating Agent Therapy Despite Significant Dose Reductions E Madarang, J Lykon, W Li, S Iyer, M Stanchina, N Nguyen, T Bradley, ... Blood 138 (Supplement 1), 1259-1259, 2021 | 3 | 2021 |
| Extramedullary Hematopoiesis of the Renal Pelvis in a Patient With Myelofibrosis M Stanchina, E Rosenbaum, AJ Pronko, Y Liu, N Lewis, M Yabe, E Stein, ... Journal of oncology practice 15 (8), 458, 2019 | 3 | 2019 |
| Use of High Dose Cytarabine (HiDAC) for Post-Remission or Re-Induction Therapy Is Safe and Effective in Select Older AML Patients J Lykon, E Madarang, N Nguyen, W Li, SG Iyer, M Stanchina, T Bradley, ... Blood 138 (Supplement 1), 4422-4422, 2021 | 2 | 2021 |
| MANAGEMENT CHALLENGES OF STRESS-INDUCED CARDIOMYOPATHY WITH DYNAMIC LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION S Lee, MR Rivera, E Wilson, BS Porres, M Stanchina, E Herzog Journal of the American College of Cardiology 71 (11S), A2413-A2413, 2018 | 1 | 2018 |
| Prediction of toxicity using metabolic tumor volume and body composition analysis in patients with advanced stage Hodgkin lymphoma undergoing treatment with BV-AVD R Kuker, M Stanchina, S Han, M Polar, LP Uribe, T Crane, F Yang, ... Journal of Nuclear Medicine 65 (supplement 2), 241241-241241, 2024 | | 2024 |
| PET/CT Enables Appropriate Staging in Extranodal Marginal Zone Lymphoma JP Alderuccio, MD Stanchina, JL Koff, IM Reis, EE Saul, MC Larson, ... Blood 142, 5134, 2023 | | 2023 |
| STAGING FDG‐AVIDITY IN EXTRANODAL MARGINAL ZONE LYMPHOMA (EMZL) BY DISEASE LOCATION. JP Alderuccio, EE Saul, M Stanchina, RH Sassi, W Zhao, C Moskowitz, ... Hematological Oncology 41, 2023 | | 2023 |
| Prevalence of COVID-19 among hematology/oncology patients and providers of a community-facing county health system during the B1. 1.529 (" Omicron") SARS-CoV-2 variant wave A Khan, SA Kareff, P Barreto-Coelho, S Iyer, B Pico, M Stanchina, ... | | 2023 |
| Trends in mortality due to hypercalcemia in breast cancer. S Perimbeti, R Shrivastav, MD Stanchina, P Pathak, MR Rainone, ... Journal of Clinical Oncology 37 (15_suppl), e18252-e18252, 2019 | | 2019 |
| EVIDENCE FOR BODY TEMPERATURE DYSREGULATION IN CHILDREN WITH FEAR OF HARM PHENOTYPE OF PEDIATRIC BIPOLAR DISORDER PJ Murphy, MA Stanchina, D Papolos SLEEP 34, A243-A243, 2011 | | 2011 |
Justin Taylor, M.D.Associate Professor, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine在 miami.edu 的电子邮件经过验证
